> [!note] > [[Biora Therapeutics]] has funded research at this lab. Resulted in a research paper: [[A Novel Capsule-Delivered Enteric Drug-Injection Device for Delivery of Systemic Biologics]] > [!quote] Research Laboratory in University of Nebraska-Lincoln > > The objectives of the TRL are to: > > - **Solve essential biomedical challenges through exceptional research and engineering** > - **Provide industry-relevant research opportunities for UNL engineering students** > - **Collaborate with local primary education to enhance K12 interest in STEM** > > Our expertise is in: > > - **Medical therapeutics, devices, and surgical tools** > - **Noninvasive, ambulatory biosensors** > - **Biomechanical behavior of tissues and organs** > - **Commercial applications of biomedical technology** > >[Home Page](https://www.unl.edu/trl/welcome-terry-research-laboratory) > [!quote] > > We ([@progenity](https://twitter.com/progenity) and TRL) dispensed [[Adalimumab|Humira]] via the intestine using our swallowable capsule platform. This means drugs that are currently only needle injected could be swallowed in their present commercial form. > > [@pfizer](https://twitter.com/pfizer) > > [@JNJInnovation](https://twitter.com/JNJInnovation) > <https://twitter.com/TerryResearch/status/1468984348758224906>